Clinical Trial Update: A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and effectiveness of a Lipiodol Ultra Fluid and glue mixture for embolization procedures in congenital hemangioma, hemangi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma
• Arteriovenous Malformations
• Congenital Hemangioma
• Hemangioendothelioma

Drugs mentioned

• Lipiodol Ultra Fluid (lipiodol (iodized oil))
• NBCA glue (n-butyl cyanoacrylate)

Snippet

Sponsor: Guerbet | Conditions: Congenital Hemangioma, Hemangioendothelioma | Phase 4 | Status: COMPLETED | Results posted: 2025-10-10